secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sunshine Biopharma Inc. (SBFM)
CIK:        0001402328
Form:       8-K
Filed at:   2023-02-13T23:59:59+00:00
Accession:  0001683168-23-000805
Event type: regulatory
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Sunshine Biopharma regains Nasdaq minimum bid price compliance
--------------------------------------------------------------

- Received Staff notice on Feb 9, 2023, confirming compliance with $1 bid price rule.
- Regained compliance removes immediate delisting risk from Nasdaq.
- Company's common stock (SBFM) and warrants (SBFMW) continue trading on Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1402328/000168316823000805/0001683168-23-000805-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1402328/000168316823000805/sunshine_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-000805

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer